AstraZeneca, FibroGen hit another roxadustat setback as FDA panel calls for more safety data esagonowsky Thu, 07/15/2021 – 16:36 More: AstraZeneca, FibroGen hit another roxadustat setback as FDA panel calls for more safety data Source: fierce
read moreTakeda, AbbVie, BMS, Sanofi, Lilly and others join growing tally of pharma’s July price hikes: report nhigginsdunn Thu, 07/15/2021 – 11:25 More: Takeda, AbbVie, BMS, Sanofi, Lilly and others join growing tally of pharma's July price hikes: report Source: fierce
read moreNovartis may have the most new drug approvals, but Roche, Lilly and AbbVie’s launches win on value: report fkansteiner Thu, 07/15/2021 – 11:22 More: Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie's launches win on
read moreBiogen’s blockbuster Tysabri loses a key patent in Europe, adding to company’s worries: analyst kdunleavy Thu, 07/15/2021 – 10:43 More: Biogen's blockbuster Tysabri loses a key patent in Europe, adding to company's worries: analyst Source: fierce
read moreFDA reprimands Amgen for ‘misleading’ Neulasta claims in banner ads aimed at doctors bbulik Thu, 07/15/2021 – 10:30 More: FDA reprimands Amgen for 'misleading’ Neulasta claims in banner ads aimed at doctors Source: fierce
read moreThere are still available spaces in the 2021 Sales Awards as we enter the last couple of months for entries. More: Spaces still available in the 2021 Sales Awards Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals